Manufacturer
Mylan Institutional Inc.
41 drugs, 95 product strengths, 9 recalls on record.
Drugs Mylan Institutional Inc. makes
Atorvastatin+2.4%Generic · 50 makersPharmacies pay from$0.699 open recallsLevothyroxine-0.4%Generic · 32 makersPharmacies pay from$1.0659 open recallsPantoprazole+2.7%Generic · 62 makersPharmacies pay from$1.103 open recallsValacyclovir+3.4%Generic · 36 makersPharmacies pay from$6.87Metoprolol+1.0%Generic · 65 makersPharmacies pay from$0.48Being discontinued9 open recallsCetirizine-4.2%Generic · 146 makersPharmacies pay from$1.365 open recallsLoratadine+3.5%Generic · 145 makersPharmacies pay from$1.641 open recallAllopurinol-1.1%Generic · 39 makersPharmacies pay from$0.94Being discontinuedSpironolactone-0.1%Generic · 35 makersPharmacies pay from$1.28Being discontinued3 open recallsBuspirone-0.8%Generic · 40 makersPharmacies pay from$0.662 open recallsMirtazapine-1.0%Generic · 31 makersPharmacies pay from$1.87Diltiazem+1.6%Generic · 34 makersPharmacies pay from$1.52Being discontinued9 open recallsLevetiracetam-1.9%Generic · 63 makersPharmacies pay from$1.702 open recallsMethotrexate+3.5%Generic · 28 makersPharmacies pay from$3.50Unavailable1 open recallFenofibrate-10.4%Generic · 42 makersPharmacies pay from$2.192 open recallsChlorthalidone-1.6%Generic · 31 makersPharmacies pay from$2.193 open recallsHydralazine-1.0%Generic · 37 makersPharmacies pay from$0.78In shortage3 open recallsLansoprazole+1.7%Generic · 57 makersPharmacies pay from$3.131 open recallSucralfate-1.9%Generic · 45 makersPharmacies pay from$5.083 open recallsLoperamide+5.2%Generic · 103 makersPharmacies pay from$1.731 open recallValproate+0.7%Generic · 52 makersPharmacies pay from$1.60Unavailable1 open recallPolyethylene glycol 3350+1.3%Generic · 42 makersPharmacies pay from$295Doxepin+4.3%Generic · 39 makersPharmacies pay from$2.391 open recallDiazepam-6.2%Generic · 38 makersPharmacies pay from$0.63Haloperidol-5.3%Generic · 33 makersPharmacies pay from$2.65Being discontinued9 open recallsVerapamil+8.8%Generic · 31 makersPharmacies pay from$2.15Being discontinued3 open recallsMetoclopramide-1.7%Generic · 34 makersPharmacies pay from$1.065 open recallsCarbidopa / levodopa-3.0%Generic · 26 makersPharmacies pay from$2.21Atenolol+1.3%Generic · 30 makersPharmacies pay from$0.66Voriconazole+8.8%Generic · 30 makersPharmacies pay from$25.005 open recallsPrazosin-0.5%Generic · 28 makersPharmacies pay from$2.49Being discontinued9 open recallsMidodrine-3.9%Generic · 25 makersPharmacies pay from$2.321 open recallImatinib+3.2%Generic · 15 makersPharmacies pay from$19.33Chlordiazepoxide-1.3%Generic · 14 makersPharmacies pay from$4.31Metolazone+1.0%Generic · 13 makersPharmacies pay from$6.79Clozapine-6.0%Generic · 9 makersPharmacies pay from$7.00Isoniazid-2.4%Generic · 13 makersPharmacies pay from$51.97Abacavir+1.2%Generic · 12 makersPharmacies pay from$16.57Hydrochlorothiazide / spironolactone+4.7%Generic · 7 makersPharmacies pay from$15.18Trifluoperazine-7.5%Generic · 5 makersPharmacies pay from$12.14Thioridazine+2.1%Generic · 3 makersPharmacies pay from$12.19
Recalls
Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0290-2025Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0291-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0131-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0132-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0133-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0134-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0135-2025Class IIOngoingDec 18, 2024Levothyroxine Sodium TabletsSubpotent and Superpotent DrugMylan Institutional, Inc. · D-0136-2025Class ITerminatedMar 20, 2019Levoleucovorin InjectionPresence of Particulate Matter: particulate matter identified as copper saltsMylan Institutional Inc · D-1059-2019
About Mylan Institutional Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.